Charalampos Skarlis

发表

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications

M. Koutsilieris, H. Moutsopoulos, C. Mavragani, 2021, Journal of clinical medicine.

Biologics in sjögren's syndrome.

C. Mavragani, Charalampos Skarlis, N. Marketos, 2019, Pharmacological research.

Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study

M. Dalakas, M. Anagnostouli, L. Stefanis, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology.

Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data

G. Chrousos, M. Dalakas, M. Anagnostouli, 2021, Neurological Sciences.

The role of insulin growth factors in autoimmune diseases

M. Koutsilieris, C. Mavragani, A. Nezos, 2019, Annals of Research Hospitals.

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals

M. Dimopoulos, O. Tsitsilonis, P. Sfikakis, 2022, Cytokine.

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome

C. Mavragani, A. Nezos, Charalampos Skarlis, 2022, Journal of clinical medicine.

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

C. Mavragani, A. Nezos, Charalampos Skarlis, 2022, Frontiers in Pharmacology.

Study of the incidence of osteoporosis in patients with Sjögren’s syndrome (pSS) and investigation of activation of the RANKL /RANK and osteoprotegerin (OPG) system

C. Mavragani, Charalampos Skarlis, Andrianos Nezos, 2018, Mediterranean journal of rheumatology.

First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center

M. Dalakas, A. Artemiadis, M. Anagnostouli, 2022, Neurological Sciences.

Sjogren’s Syndrome: Recent Updates

C. Mavragani, Charalampos Skarlis, S. Raftopoulou, 2022, Journal of clinical medicine.

HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort

A. Artemiadis, M. Anagnostouli, L. Stefanis, 2019, Postgraduate medicine.

Type I interferon detection in autoimmune diseases: challenges and clinical applications

C. Mavragani, Charalampos Skarlis, M. Evangelopoulos, 2021, Expert review of clinical immunology.

The role of melatonin in Multiple Sclerosis

M. Anagnostouli, Charalampos Skarlis, 2019, Neurological Sciences.

HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort

A. Artemiadis, M. Anagnostouli, L. Stefanis, 2020, Brain sciences.

Immune Dysfunction and Drug Targets in Autoinflammatory Syndromes

C. Mavragani, Charalampos Skarlis, 2021, Reference Module in Biomedical Sciences.

Lymphoma in Sjögren’s Syndrome: Predictors and Therapeutic Options

C. Mavragani, Charalampos Skarlis, E. Argyriou, 2020, Current Treatment Options in Rheumatology.

Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes

N. Sipsas, C. Mavragani, Charalampos Skarlis, 2022, Frontiers in Medicine.

Multiple Sclerosis and Subsequent Human Immunodeficiency Virus Infection: A Case with the Rare Comorbidity, Focus on Novel Treatment Issues and Review of the Literature.

M. Anagnostouli, Charalampos Skarlis, P. Toulas, 2017, In vivo.

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?

M. Koutsilieris, A. Tzioufas, H. Moutsopoulos, 2021, Frontiers in Immunology.

Atherosclerosis in SLE: a potential role for serum parathormone levels

H. Moutsopoulos, C. Mavragani, Charalampos Skarlis, 2020, Lupus science & medicine.

Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.

R. Gavioli, A. Caputo, B. Ensoli, 2016, Vaccine.

HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort

G. Chrousos, M. Dalakas, A. Artemiadis, 2020, Multiple sclerosis journal - experimental, translational and clinical.

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies

D. Vassilopoulos, C. Mavragani, Charalampos Skarlis, 2023, Mediterranean journal of rheumatology.